Clinical, reimbursement & partnerships for the orphan drug industry

Rare disease patient advocacy groups, payers, regulators and industry – Who will you make time to meet? This year, the 3rd Annual World Orphan Drug Congress Europe has evolved to differentiate itself and provide the most comprehensive and focused event for the rare disease industry. Wherever you are in your portfolio lifecycle and whatever your commercial objectives are for the …